In vivo efficacy of the recombinant anti-CD64 immunotoxin H22(scFv)-ETA′ in a human acute myeloid leukemia xenograft tumor model
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In vivo efficacy of the recombinant anti-CD64 immunotoxin H22(scFv)-ETA′ in a human acute myeloid leukemia xenograft tumor model
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 129, Issue 5, Pages 1277-1282
Publisher
Wiley
Online
2010-11-12
DOI
10.1002/ijc.25766
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recombinant, ETA′-based CD64 immunotoxins: improved efficacy by increased valency, both in vitro and in vivo in a chronic cutaneous inflammation model in human CD64 transgenic mice
- (2010) T. Ribbert et al. BRITISH JOURNAL OF DERMATOLOGY
- Current and emerging therapies for acute myeloid leukemia
- (2010) Tadeusz Robak et al. CLINICAL THERAPEUTICS
- Antibody Internalization after Cell Surface Antigen Binding is Critical for Immunotoxin Development
- (2009) Shu-Ru Kuo et al. BIOCONJUGATE CHEMISTRY
- Recombinant Immunotoxins Containing Truncated Bacterial Toxins for the Treatment of Hematologic Malignancies
- (2009) Robert J. Kreitman BIODRUGS
- Association of MLL amplification with poor outcome in acute myeloid leukemia
- (2009) Robert W. Maitta et al. CANCER GENETICS AND CYTOGENETICS
- Impact of new prognostic markers in treatment decisions in acute myeloid leukemia
- (2009) Richard F Schlenk et al. CURRENT OPINION IN HEMATOLOGY
- Fcγ Receptor 1 (CD64), a Target Beyond Cancer
- (2009) T. Thepen et al. CURRENT PHARMACEUTICAL DESIGN
- Immunokinases, a Novel Class of Immunotherapeutics for Targeted Cancer Therapy
- (2009) Mehmet Tur et al. CURRENT PHARMACEUTICAL DESIGN
- Antibody-based therapy of leukaemia
- (2009) John C. Morris et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Small Cleavable Adapters Enhance the Specific Cytotoxicity of a Humanized Immunotoxin Directed Against CD64-positive Cells
- (2009) Christian Hetzel et al. JOURNAL OF IMMUNOTHERAPY
- Antibody-Drug Conjugates for Cancer Therapy
- (2008) Paul J. Carter et al. CANCER JOURNAL
- Anthracycline Cardiotoxicity: From Bench to Bedside
- (2008) Luca Gianni et al. JOURNAL OF CLINICAL ONCOLOGY
- Investigating human leukemogenesis: from cell lines to in vivo models of human leukemia
- (2008) J A Kennedy et al. LEUKEMIA
- Granzyme B-H22(scFv), a human immunotoxin targeting CD64 in acute myeloid leukemia of monocytic subtypes
- (2008) B. Stahnke et al. MOLECULAR CANCER THERAPEUTICS
- Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
- (2008) Richard F. Schlenk et al. NEW ENGLAND JOURNAL OF MEDICINE
- An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes
- (2008) M. Onda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started